According to Protagonist Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 24.9624. At the end of 2023 the company had a P/S ratio of 22.0.
Year | P/S ratio | Change |
---|---|---|
2023 | 22.0 | 9.16% |
2022 | 20.2 | -66.16% |
2021 | 59.7 | 96.96% |
2020 | 30.3 | -96.35% |
2019 | 831 | 16361.66% |
2018 | 5.05 | -76.83% |
2017 | 21.8 | |
2016 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |